FPF
VRTX icon

First Pacific Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

First Pacific Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682K Sell
1,373
-47
-3% -$20.8K 0.08% 106
2026
Q1 		$634K Buy
1,420
+8
+0.6% +$3.73K 0.08% 110
2025
Q4 		$640K Sell
1,412
-39
-3% -$16.8K 0.08% 113
2025
Q3 		$568K Sell
1,451
-14
-1% -$5.85K 0.08% 120
2025
Q2 		$652K Sell
1,465
-116
-7% -$53.5K 0.1% 111
2025
Q1 		$767K Sell
1,581
-144
-8% -$67.1K 0.16% 78
2024
Q4 		$695K Buy
1,725
+747
+76% +$346K 0.16% 93
2024
Q3 		$455K Buy
978
+54
+6% +$25.9K 0.11% 102
2024
Q2 		$433K Buy
924
+26
+3% +$11.3K 0.11% 101
2024
Q1 		$375K Buy
898
+62
+7% +$26.2K 0.1% 102
2023
Q4 		$340K Buy
836
+53
+7% +$19.6K 0.1% 105
2023
Q3 		$272K Buy
783
+162
+26% +$56.7K 0.12% 100
2023
Q2 		$219K Buy
+621
New +$209K 0.09% 104

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

First Pacific Financial's VRTX Position: Q2 2026 in Review

First Pacific Financial reduced its Vertex Pharmaceuticals (VRTX) stake by 3.3% in Q2 2026, selling an estimated $20.8K and leaving 1,373 shares worth $682K. The position accounts for 0.08% of the portfolio, ranked #106.

First Pacific Financial first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $767K in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • First Pacific Financial held 1,373 shares of Vertex Pharmaceuticals worth $682K as of Q2 2026.
  • First Pacific Financial sold 47 Vertex Pharmaceuticals shares in Q2 2026, an estimated $20.8K.
  • Vertex Pharmaceuticals made up 0.08% of First Pacific Financial's portfolio in Q2 2026, its #106 holding.
  • First Pacific Financial first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • First Pacific Financial's Vertex Pharmaceuticals position peaked at $767K in Q1 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on First Pacific Financial's 13F filing for Q2 2026, filed 20 Jul 2026.